November 8, 2019
09:00 - 09:30
Tuberculosis is, together with AIDS, the most deadly infectious disease in the world. As for other diseases, genome sequencing technologies are mature enough to make a leap forward to routine TB care, surveillance and control. However, the question about how disruptive this new technology for TB is is still debated. I will review current evidence, including research from my laboratory, showing how transformative genome sequencing has been, and likely will be, in TB. I will also highlight current pitfalls and challenges for the future including programmatic implementation and integration in the diagnostic environment.
Speaker: Iñaki Comas, Biomedicine Institute of Valencia, Spain